시장보고서
상품코드
2060251

수의 보조 생식 기술 시장 분석 및 예측 : 유형, 제품 유형, 서비스, 기술, 구성요소, 용도, 최종 사용자, 기능, 기기, 솔루션(-2035년)

Veterinary Assistive Reproduction Technology Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Functionality, Equipment, Solutions

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 7,409,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 8,969,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 10,529,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수의 보조 생식 기술 세계 시장은 2025년 32억 달러에서 2035년까지 55억 달러로 성장하여 CAGR은 5.4%를 나타낼 것으로 예측됩니다. 수의 보조 생식 기술 시장은 적정 수준의 통합 구조를 특징으로 하며, 인공수정 부문이 약 45%의 시장 점유율로 선두를 차지하고 있고, 그 다음으로 배아 이식이 30%, 체외수정이 25%를 차지하고 있습니다. 주요 용도로는 가축 번식, 반려동물 번식, 그리고 멸종 위기 종의 보전이 포함됩니다. 이 시장에서는 특히 가축 분야에서 연간 수백만 건의 인공수정 등이 이루어지는 등 상당한 수의 시술이 시행되고 있습니다.

기술 유형별로는 주로 인공수정 및 배아 이식 기술이 시장을 주도하고 있으며, 이들은 가축 육종 프로그램에서 광범위하게 채택됨에 따라 시장을 장악하고 있습니다. 이러한 기술은 젖소 및 육우 산업에서 유전적 형질의 향상과 생산성 개선에 필수적입니다. 고품질 축산물에 대한 수요 증가와 효율적인 육종 솔루션에 대한 수요가 이 부문의 성장을 이끄는 주요 요인입니다. 체외수정 등 신기술도 생식 생명공학의 발전을 반영하여 주목을 받고 있습니다.

기술 분야는 동결보존 및 유전체 선별 분야에서 눈부신 진전이 이루어진 것이 특징입니다. 동결보존은 향후 사용을 위한 유전 물질의 보존에 있어 매우 중요한 역할을 하며, 육종 프로그램에서 유전적 다양성과 지속성을 확보하기 위해 핵심적인 위치를 차지하고 있습니다. 유전체 선별은 유전자 매핑 및 시퀀싱 기술의 발전에 힘입어, 육종의 정확성과 효율성을 높이기 위해 점점 더 널리 활용되고 있습니다. 이러한 기술에 빅데이터 분석과 머신러닝을 통합함으로써, 그 도입과 효과성이 더욱 가속화될 것으로 기대됩니다.

용도 부문에서는 가축의 품질과 생산성을 향상시켜야 할 필요성 때문에 가축 육종이 주도적인 위치를 차지하고 있습니다. 소, 돼지, 가금류 산업에서 질병 저항성 및 성장률 등 유전적 형질의 향상에 주력하는 것이 주요 성장 요인이 되고 있습니다. 또한, 희귀 품종의 보존과 반려동물의 건강 증진이라는 관점에서 반려동물 육종도 주목을 받고 있습니다. 동물 복지에 대한 소비자의 인식 제고와 최적화된 육종 프로그램이 가져오는 경제적 이익이 이 부문을 지탱하는 주요 동력이 되고 있습니다.

지역별 개요

북미는 선진적인 가축 관리 기법과 주요 유전학 및 동물 육종 기업의 강력한 입지 덕분에 수의 보조 생식 기술 시장을 독점하고 있습니다. 이 지역에는 인공수정 및 배아 이식 등의 기술을 위한 확립된 인프라가 갖춰져 있어, 젖소와 육우 생산 시스템 전반에 걸쳐 대규모 도입이 가능합니다. 동물의 생산성, 유전적 품질 및 지속 가능한 식량 생산 향상에 대한 높은 관심 또한 수요를 더욱 부추기고 있습니다. 또한, 지속적인 조사 투자, 견고한 상업 네트워크, 그리고 혁신적인 생식 기술의 조기 도입이 세계 시장에서 이 지역의 선도적인 입지를 공고히 하는 데 기여하고 있습니다.

아시아태평양은 막대한 가축 사육 두수와 동물성 단백질 수요 증가에 힘입어, 수의 보조 생식 기술 시장에서 가장 빠르게 성장하고 있는 지역입니다. 첨단 번식 기술에 대한 농가들의 인식이 높아지는 데 더해, 가축 생산성을 높이기 위한 정부의 지원책이 기술 도입을 가속화하고 있습니다. 수의학 인프라의 급속한 발전과 축산 분야로의 투자 증가 또한 시장 확대를 더욱 촉진하고 있습니다. 이 지역의 각국에서는 번식 효율을 높이기 위해 인공수정이나 체외수정 등의 기술 도입이 점점 더 확대되고 있으며, 아시아태평양은 시장의 중요한 성장 거점이 되고 있습니다.

주요 동향 및 촉진요인

동물성 단백질 및 첨단 번식 기술에 대한 수요 증가:

육류, 유제품 및 기타 동물성 제품에 대한 전 세계적인 수요 증가는 수의 보조 생식 기술 시장의 주요 성장 동력이 되고 있습니다. 축산 농가들은 생산성, 유전적 품질 및 번식 효율을 높이기 위해 인공수정, 배아 이식, 체외수정 등 첨단 번식 기술을 점점 더 많이 도입하고 있습니다. 이러한 기술은 가축군의 생산성, 질병 저항성 및 총 생산량 향상에 기여하며, 지속 가능한 축산업에 있어 필수적인 요소로 자리 잡고 있습니다. 게다가, 축산 분야로의 투자 확대와 번식 성과 향상에 대한 관심이 높아지면서 선진국과 신흥 시장 모두에서 이러한 기술의 도입이 가속화되고 있습니다.

신흥 시장에서의 확장과 생명공학의 발전:

가축 사육 두수가 많고, 첨단 생식 기술의 도입이 아직 발전 단계에 있는 신흥 경제국에는 큰 비즈니스 기회가 존재합니다. 농가들의 인식 제고, 수의학 인프라 개선, 그리고 정부의 지원책이 현대적인 번식 기술의 도입을 뒷받침하고 있습니다. 또한, 생명공학, 유전체학, 정밀 번식 기술의 발전으로 인해 더욱 효율적이고 목표가 명확한 번식 전략이 가능해졌습니다. 유전자 스크리닝과 생식 진단의 통합을 통해 번식 성공률과 가축의 품질이 더욱 향상되고 있습니다. 이러한 혁신 기술과 인도, 중국 등 국가들의 농업 부문 확대가 맞물리면서, 전 세계 시장 관계자들에게 강력한 성장 기회가 창출되고 있습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 당사에 대해

JHS 26.06.19

The global Veterinary Assistive Reproduction Technology Market is projected to grow from $3.2 billion in 2025 to $5.5 billion by 2035, at a compound annual growth rate (CAGR) of 5.4%. The Veterinary Assistive Reproduction Technology Market is characterized by a moderately consolidated structure, with the artificial insemination segment leading at approximately 45% market share, followed by embryo transfer at 30%, and in vitro fertilization at 25%. Key applications include livestock breeding, companion animal reproduction, and conservation of endangered species. The market sees a substantial volume of procedures, particularly in livestock, with millions of inseminations conducted annually.

In the Type segment, the market is primarily driven by artificial insemination and embryo transfer technologies, which dominate due to their widespread adoption in livestock breeding programs. These technologies are crucial for enhancing genetic traits and improving productivity in dairy and beef cattle industries. The increasing demand for high-quality animal products and the need for efficient breeding solutions are key factors propelling growth in this segment. Emerging techniques such as in vitro fertilization are gaining traction, reflecting advancements in reproductive biotechnologies.

Market Segmentation
TypeArtificial Insemination, Embryo Transfer, In Vitro Fertilization, Semen Collection, Semen Freezing, Semen Analysis, Others
ProductSemen Extenders, Embryo Transfer Kits, Cryopreservation Media, Insemination Equipment, Semen Collection Devices, Others
ServicesConsultation Services, Training Services, Genetic Testing, Veterinary Support, Others
TechnologyCryopreservation, Ultrasound Technology, Micromanipulation, Flow Cytometry, Others
ComponentConsumables, Instruments, Software, Others
ApplicationCattle, Equine, Swine, Canine, Feline, Others
End UserVeterinary Clinics, Animal Breeding Centers, Research Institutes, Others
FunctionalityDiagnostic, Therapeutic, Monitoring, Others
EquipmentIncubators, Centrifuges, Sperm Analyzers, Others
SolutionsFertility Management, Genetic Improvement, Animal Health Monitoring, Others

The Technology segment is characterized by significant advancements in cryopreservation and genomic selection. Cryopreservation dominates due to its critical role in preserving genetic material for future use, ensuring genetic diversity and continuity in breeding programs. Genomic selection is increasingly utilized to enhance breeding accuracy and efficiency, driven by advancements in genetic mapping and sequencing technologies. The integration of big data analytics and machine learning in these technologies is expected to further accelerate their adoption and effectiveness.

In the Application segment, livestock breeding holds a dominant position, driven by the need to improve herd quality and productivity. The focus on enhancing genetic traits such as disease resistance and growth rates in cattle, swine, and poultry industries is a major growth driver. Companion animal breeding is also gaining attention, particularly in the context of preserving rare breeds and enhancing pet health. The rising consumer awareness of animal welfare and the economic benefits of optimized breeding programs are key trends supporting this segment.

Geographical Overview

North America dominates the veterinary assistive reproduction technology market due to its advanced livestock management practices and strong presence of leading genetics and animal breeding companies. The region has a well-established infrastructure for technologies such as artificial insemination and embryo transfer, enabling large-scale adoption across dairy and meat production systems. High focus on improving animal productivity, genetic quality, and sustainable food production further drives demand. In addition, continuous investment in research, strong commercial networks, and early adoption of innovative reproductive technologies contribute to the region's leading position in the global market.

Asia Pacific is the fastest-growing region in the veterinary assistive reproduction technology market, driven by its large livestock population and increasing demand for animal protein. Growing awareness among farmers about advanced breeding techniques, along with supportive government initiatives to enhance livestock productivity, is accelerating adoption. Rapid development in veterinary infrastructure and rising investments in animal husbandry are further supporting market expansion. Countries across the region are increasingly adopting technologies such as artificial insemination and in vitro fertilization to improve breeding efficiency, making Asia Pacific a key growth hub for the market.

Key Trends and Drivers

Increasing Demand for Animal Protein and Advanced Breeding Techniques:

The rising global demand for meat, milk, and other animal-derived products is a major driver for the veterinary assistive reproduction technology market. Livestock producers are increasingly adopting advanced reproductive techniques such as artificial insemination, embryo transfer, and in vitro fertilization to improve productivity, genetic quality, and breeding efficiency. These technologies help enhance herd performance, disease resistance, and overall output, making them essential for sustainable animal husbandry. Additionally, growing investments in livestock farming and increasing focus on improving breeding outcomes are accelerating the adoption of these technologies across both developed and emerging markets.

Expansion in Emerging Markets and Advancements in Biotechnology:

Significant opportunities exist in emerging economies where livestock populations are large and adoption of advanced reproductive technologies is still developing. Increasing awareness among farmers, improving veterinary infrastructure, and supportive government initiatives are encouraging the use of modern breeding techniques. Additionally, advancements in biotechnology, genomics, and precision breeding are enabling more efficient and targeted reproduction strategies. Integration of genetic screening and reproductive diagnostics is further enhancing breeding success rates and animal quality. These innovations, combined with expanding agricultural sectors in countries such as India and China, are creating strong growth opportunities for market players globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Equipment
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Artificial Insemination
    • 4.1.2 Embryo Transfer
    • 4.1.3 In Vitro Fertilization
    • 4.1.4 Semen Collection
    • 4.1.5 Semen Freezing
    • 4.1.6 Semen Analysis
    • 4.1.7 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Semen Extenders
    • 4.2.2 Embryo Transfer Kits
    • 4.2.3 Cryopreservation Media
    • 4.2.4 Insemination Equipment
    • 4.2.5 Semen Collection Devices
    • 4.2.6 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consultation Services
    • 4.3.2 Training Services
    • 4.3.3 Genetic Testing
    • 4.3.4 Veterinary Support
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Cryopreservation
    • 4.4.2 Ultrasound Technology
    • 4.4.3 Micromanipulation
    • 4.4.4 Flow Cytometry
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Consumables
    • 4.5.2 Instruments
    • 4.5.3 Software
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Cattle
    • 4.6.2 Equine
    • 4.6.3 Swine
    • 4.6.4 Canine
    • 4.6.5 Feline
    • 4.6.6 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Veterinary Clinics
    • 4.7.2 Animal Breeding Centers
    • 4.7.3 Research Institutes
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Diagnostic
    • 4.8.2 Therapeutic
    • 4.8.3 Monitoring
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Incubators
    • 4.9.2 Centrifuges
    • 4.9.3 Sperm Analyzers
    • 4.9.4 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Fertility Management
    • 4.10.2 Genetic Improvement
    • 4.10.3 Animal Health Monitoring
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Equipment
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Equipment
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Equipment
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Equipment
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Equipment
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Equipment
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Equipment
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Equipment
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Equipment
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Equipment
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Equipment
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Equipment
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Equipment
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Equipment
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Equipment
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Equipment
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Equipment
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Equipment
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Equipment
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Equipment
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Equipment
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Equipment
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Equipment
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Equipment
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Zoetis
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Vetoquinol
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 IMV Technologies
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Minitube International
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 AB Technology
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Paragon Veterinary Group
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Select Sires
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Genus ABS
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 CRV
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Cogent Breeding
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Semex
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Alta Genetics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Genex Cooperative
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Trans Ova Genetics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Bovine Elite
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 STgenetics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Universal Semen Sales
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Accelerated Genetics
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Genus PIC
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Neogen Corporation
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기